These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 6539098)

  • 21. [Combined chemotherapy with cisplatin in esophageal cancer].
    Fukui H; Ide H; Hanyu F; Yamada A; Murata Y; Okushima N
    Gan To Kagaku Ryoho; 1987 Oct; 14(10):2865-9. PubMed ID: 2444165
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mitomycin C, vinblastine, and carboplatin regimen in patients with nonsmall cell lung cancer. A phase II trial.
    Paccagnella A; Favaretto A; Oniga F; Festi G; Lauro S; Morabito A; Ossana L; Sartore F; DePoli F; Fiorentino MV
    Cancer; 1996 Oct; 78(8):1701-7. PubMed ID: 8859183
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cisplatin, vinblastine, and mitoguazone in squamous cell carcinoma of the esophagus: a Southwest Oncology Group Study.
    Chapman R; Fleming TR; Van Damme J; Macdonald J
    Cancer Treat Rep; 1987 Dec; 71(12):1185-7. PubMed ID: 3690527
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [A cooperative phase II study of vindesine sulfate in patients with solid tumors].
    Gan To Kagaku Ryoho; 1983 Sep; 10(9):2036-42. PubMed ID: 6614938
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Advances in chemotherapy of esophageal cancer.
    Kelsen DP
    Clin Bull; 1981; 11(3):131-8. PubMed ID: 6175446
    [No Abstract]   [Full Text] [Related]  

  • 26. [Combination vindesine, cyclophosphamide, cis-platinum and CCNU in esophageal epidermoid cancer. Preliminary analysis of 64 cases].
    Spielmann M; Kac J; Elias D; Caille P; Le Chevalier T; Rougier P; Zummer K; Lasser P; Rouesse J
    Bull Cancer; 1985; 72(3):220-6. PubMed ID: 4074907
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Combination chemotherapy with cis-dichlorodiammineplatinum (11) (CDDP) and bleomycin BLM in advanced esophageal carcinoma].
    Hayakawa M; Morise K; Iizuka A; Kato H; Ohno R; Goto T; Hayashi N; Ishii M; Sakai T; Kimura K
    Gan No Rinsho; 1985 Feb; 31(2):122-7. PubMed ID: 2580999
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Cisplatin plus 5-fluorouracil combination therapy in the treatment of advanced esophageal cancer: a report of 156 cases].
    Wang L; Li X; Wang R
    Zhonghua Zhong Liu Za Zhi; 1999 Sep; 21(5):389-91. PubMed ID: 11776584
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A phase II evaluation of high dose cisplatin and etoposide in patients with advanced esophageal adenocarcinoma.
    Spiridonidis CH; Laufman LR; Jones JJ; Gray DJ; Cho CC; Young DC
    Cancer; 1996 Nov; 78(10):2070-7. PubMed ID: 8918399
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cisplatin plus vinorelbine as induction chemotherapy followed by surgery in the treatment of stage IIIB non-small cell lung cancer. Final results of a multicenter phase II study.
    Cigolari S; Curcio C; Maiorino A; Sessa R; Cioffi A; Massimo M
    Anticancer Res; 2003; 23(2C):1803-9. PubMed ID: 12820462
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Radiotherapy combined with S-1 and cisplatin for locally advanced and metastatic esophageal cancer].
    Iwase H
    Gan To Kagaku Ryoho; 2006 Jun; 33 Suppl 1():224-9. PubMed ID: 16898007
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Concurrent versus sequential chemoradiotherapy with cisplatin and vinorelbine in locally advanced non-small cell lung cancer: a randomized study.
    Zatloukal P; Petruzelka L; Zemanova M; Havel L; Janku F; Judas L; Kubik A; Krepela E; Fiala P; Pecen L
    Lung Cancer; 2004 Oct; 46(1):87-98. PubMed ID: 15364136
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A phase II study of weekly methotrexate, cisplatin, and 24-hour infusion of high-dose 5-fluorouracil and leucovorin (MP-HDFL) in patients with metastatic and recurrent esophageal cancer-improving toxicity profile by infusional schedule and double biochemical modulation of 5-fluorouracil.
    Hsu CH; Cheng AL; Hsu C; Yang CH; Lu YS; Lin CC; Bu CF; Yeh KH
    Anticancer Res; 2002; 22(6B):3621-7. PubMed ID: 12552966
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of patients with upper gastrointestinal carcinomas.
    Ajani JA
    Semin Oncol; 1997 Dec; 24(6 Suppl 19):S19-72-S19-76. PubMed ID: 9427271
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Mitomycin, vindesine and cisplatin combination therapy in the treatment of advanced non-small cell lung cancer: a report of 108 cases].
    Zhang X; Sun Y; Feng F
    Zhonghua Zhong Liu Za Zhi; 1999 May; 21(3):220-3. PubMed ID: 11776842
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combination chemotherapy of cisplatin, methotrexate, vinblastine, and high-dose tamoxifen for transitional cell carcinoma.
    Hsu CH; Chen J; Wu CY; Cheng AL; Pu YS
    Anticancer Res; 2001; 21(1B):711-5. PubMed ID: 11299831
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cisplatin and ifosfamide with various doses of vinorelbine (navelbine) in advanced non-small lung cancer.
    Souquet PJ; Fournel P; Bohas CH; Fortune IC; Chatte G
    Semin Oncol; 1996 Apr; 23(2 Suppl 5):8-10. PubMed ID: 8610239
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vindesine in the treatment of esophageal carcinoma: a phase II study.
    Kelsen DP; Bains M; Cvitkovic E; Golbey R
    Cancer Treat Rep; 1979; 63(11-12):2019-21. PubMed ID: 526935
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vindesine/cisplatin chemotherapy in relapsed or primarily resistant small-cell carcinoma of the lung.
    Niederle N; Schütte J; Krischke W; Seeber S; Schmidt CG
    Klin Wochenschr; 1984 Aug; 62(16):783-6. PubMed ID: 6090762
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Chemotherapy of advanced non-small cell bronchogenic carcinoma with cisplatin and vindesine].
    Drings P; Kleckow M; Manke HG; Stiefel E
    Onkologie; 1984 Aug; 7(4):202-4. PubMed ID: 6384861
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.